RecruitingNCT06075771
L-DOPA or placebo for low motivation during depression with inflammation
About this title
Read the official source — NCT06075771Researchers are comparing Carbidopa Levodopa and placebo to find out how the approaches affect depression symptoms in people with depression.
Medication studyAges 25–55United States
Understand this study
What is this study about?
Researchers are comparing Carbidopa Levodopa and placebo to find out how the approaches affect depression symptoms in people with depression.
Who could participate?
This study is for people with depression. Listed age limits: 25 years to 55 years. Other eligibility criteria apply.
- Listed locations
- AtlantaSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: November 21, 2023
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 70
- Sponsor
- Emory University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 25 Years to 55 Years
- Official registry ID
- NCT06075771
- Official title
Show the full official title
Dopaminergic Therapy for Inflammation-Related Anhedonia in Depression - 2
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Atlanta
Interested in joining this study?
Questions about this study
What is this study about?
Researchers are comparing Carbidopa Levodopa and placebo to find out how the approaches affect depression symptoms in people with depression.
Who is behind this study?
The study sponsor is Emory University, a university.
Does this study involve medication?
Yes. The study involves medication, including Carbidopa Levodopa and Placebo.
Who can participate?
This study is for people with depression. Listed age limits: 25 years to 55 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as recruiting.
